{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:28:04Z","timestamp":1791041284248,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["202110149"],"award-info":[{"award-number":["202110149"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H05876"],"award-info":[{"award-number":["JP20H05876"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K20517"],"award-info":[{"award-number":["JP21K20517"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K18197"],"award-info":[{"award-number":["JP22K18197"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008656","name":"Iketani Science and Technology Foundation","doi-asserted-by":"publisher","award":["0341060-A"],"award-info":[{"award-number":["0341060-A"]}],"id":[{"id":"10.13039\/501100008656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jconrel.2023.04.010","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T19:57:50Z","timestamp":1681847870000},"page":"885-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues"],"prefix":"10.1016","volume":"361","author":[{"given":"Kenta","family":"Tanito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Nii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Hijii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuya","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.04.010_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2015.01.039","article-title":"Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer","volume":"204","author":"Fu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1634\/theoncologist.10-3-205","article-title":"Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer","volume":"10","author":"Rose","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0015","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acsnano.2c03573","article-title":"Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1389200216888150915112039","article-title":"Role of drug metabolism in the cytotoxicity and clinical efficacy of anthracyclines","volume":"16","author":"Edwardson","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01218520","article-title":"Difficulties defining the role of high-dose chemotherapy in the management of breast cancer","volume":"121","author":"Markman","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00228-016-2030-4","article-title":"Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment","volume":"72","author":"de Vries Schultink","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0045","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","article-title":"Immune suppressive mechanisms in the tumor microenvironment","volume":"39","author":"Munn","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","article-title":"Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention","volume":"16","author":"Whiteside","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0065","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"72","author":"Facciabene","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1611-7","article-title":"Unleashing endogenous TNF-alpha as a cancer immunotherapeutic","volume":"16","author":"Josephs","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0080","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/ATVBAHA.111.225508","article-title":"C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype","volume":"31","author":"Devaraj","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2019.04.032","article-title":"IL-6 induced M1 type macrophage polarization increases radiosensitivity in HPV positive head and neck cancer","volume":"456","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4137\/BCI.S901","article-title":"Targeted cancer therapy with tumor necrosis factor-alpha","volume":"1","author":"Cai","year":"2008","journal-title":"Biochem. Insights."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0110","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1038\/srep13595","article-title":"A novel recombinant slow-release TNF \u03b1-derived peptide effectively inhibits tumor growth and angiogenesis","volume":"5","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-82","article-title":"Proteolytic activation of Proapoptotic kinase protein kinase C\u03b4 by tumor necrosis factor \u03b1 death receptor signaling in dopaminergic neurons during neuroinflammation","volume":"9","author":"Gordon","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/15216540600981743","article-title":"Construction, expression, and characterization of a new targeted bifunctional fusion protein: Tumstatin45-132-TNF","volume":"58","author":"Luo","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bcp.2007.10.013","article-title":"The immunocytokine scFv23\/TNF targeting HER-2\/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines","volume":"75","author":"Lyu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-14-0862","article-title":"Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments","volume":"14","author":"Loganzo","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.2609","article-title":"Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in colorectal cancer","volume":"18","author":"Montagut","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0140","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768758","article-title":"CXC and CC chemokines as angiogenic modulators in nonhaematological tumor","author":"Santoni","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41587-019-0064-8","article-title":"Engineered immune cells as highly sensitive cancer diagnostics","volume":"37","author":"Aalipour","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","author":"Roszer","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0170","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.micinf.2015.03.006","article-title":"Macrophages expressing arginase 1 and nitric oxide synthase 2 accumulate in the small intestine during Giardia lamblia infection","volume":"17","author":"Maloney","year":"2015","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0175","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: an emerging key player in the mammalian immune system: REVIEW","volume":"158","author":"Munder","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0180","article-title":"Early growth response gene-2 is essential for M1 and M2 macrophage activation and plasticity by modulation of the transcription factor CEBP\u03b2","volume":"9","author":"Veremeyko","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0185","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.4049\/jimmunol.172.12.7565","article-title":"Enhancer-mediated control of macrophage-specific arginase I expression","volume":"172","author":"Pauleau","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0195","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/1940-6207.CAPR-12-0488","article-title":"Vitamin D receptor and retinoid X receptor \u03b1 status and vitamin D insufficiency in models of murine colitis","volume":"6","author":"Knackstedt","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0205","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0210","first-page":"817","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers","volume":"15","author":"McGill","year":"2016","journal-title":"EXCLI J."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0215","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.4049\/jimmunol.171.9.4708","article-title":"IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B","volume":"171","author":"Lin","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0220","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00705-016-2768-0","article-title":"Regulation of CCAAT\/enhancer-binding protein (C\/EBP) \u03b1 in human-cytomegalovirus-infected fibroblasts","volume":"161","author":"Lee","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2016.01.026","article-title":"Delivery strategies to control inflammatory response: modulating M1\u2013M2 polarization in tissue engineering applications","volume":"240","author":"Alvarez","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1-M2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0235","series-title":"Macrophage-Tumor Chimeric Exosomes Accumulate in Lymph Node and Tumor to Activate the Immune Response and the Tumor Microenvironment","volume":"13","author":"Wang","year":"2021"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-\u03b1 in Cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"Horssen","year":"2006","journal-title":"Oncologist."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-017-0721-9","article-title":"Tumor-related interleukins: old validated targets for new anti-cancer drug development","volume":"16","author":"Setrerrahmane","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2023.04.010_bb0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","article-title":"Targeting of IL-4 and IL-13 receptors for cancer therapy","volume":"75","author":"Suzuki","year":"2015","journal-title":"Cytokine."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15384047.2017.1394538","article-title":"Modulating secreted components of tumor microenvironment: a masterstroke in tumor therapeutics","volume":"19","author":"Patel","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062998","article-title":"Involvement of IL-4, IL-13 and their receptors in pancreatic cancer","volume":"22","author":"Shi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2005.01087.x","article-title":"Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells","volume":"25","author":"Sugimoto","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molimm.2004.04.027","article-title":"STAT-1 is activated by IL-4 and IL-13 in multiple cell types","volume":"41","author":"Wang","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-018-3735-0","article-title":"Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?","volume":"83","author":"Zheng","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-019-0513-z","article-title":"A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy","volume":"17","author":"Qiang","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0285","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/cas.14455","article-title":"TNF-\u03b1 enhances TGF-\u03b2-induced endothelial-to-mesenchymal transition via TGF-\u03b2 signal augmentation","volume":"111","author":"Yoshimatsu","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0290","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/iai.64.5.1846-1849.1996","article-title":"Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway","volume":"64","author":"Roy","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0295","first-page":"5602","article-title":"Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients","volume":"51","author":"Aderka","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001356","article-title":"Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses","volume":"8","author":"Brempelis","year":"2020","journal-title":"J. Immunother Cancer."},{"key":"10.1016\/j.jconrel.2023.04.010_bb0305","series-title":"Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity","first-page":"2549","volume":"105","author":"Munder","year":"2005"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:58:10Z","timestamp":1759165090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":61,"alternative-id":["S0168365923002602"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.010","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}